Predicting tumour radiosensitivity to deliver precision radiotherapy

JM Price, A Prabhakaran, CML West - Nature Reviews Clinical …, 2023 - nature.com
Owing to advances in radiotherapy, the physical properties of radiation can be optimized to
enable individualized treatment; however, optimization is rarely based on biological …

[HTML][HTML] Nanotechnology advances in the detection and treatment of cancer: an overview

S Mosleh-Shirazi, M Abbasi, M reza Moaddeli… - …, 2022 - ncbi.nlm.nih.gov
Over the last few years, progress has been made across the nanomedicine landscape, in
particular, the invention of contemporary nanostructures for cancer diagnosis and …

The association between tumor mutational burden and prognosis is dependent on treatment context

C Valero, M Lee, D Hoen, J Wang, Z Nadeem, N Patel… - Nature …, 2021 - nature.com
In multiple cancer types, high tumor mutational burden (TMB) is associated with longer
survival after treatment with immune checkpoint inhibitors (ICIs). The association of TMB with …

[HTML][HTML] Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine

SS Bashraheel, A Domling, SK Goda - Biomedicine & Pharmacotherapy, 2020 - Elsevier
Background Until recently, patients who have the same type and stage of cancer all receive
the same treatment. It has been established, however, that individuals with the same …

Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging

BS Purohit, MI Vargas, A Ailianou, L Merlini… - Insights into …, 2016 - Springer
Although the orbit is a small anatomical space, the wide range of structures present within it
are often the site of origin of various tumours and tumour-like conditions, both in adults and …

Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities

S Liebs, T Eder, F Klauschen, M Schütte, ML Yaspo… - Oncogene, 2021 - nature.com
Genetic investigation of tumor heterogeneity and clonal evolution in solid cancers could be
assisted by the analysis of liquid biopsies. However, tumors of various entities might release …

[HTML][HTML] Clinical applications of PET/MRI: current status and future perspectives

F Nensa, K Beiderwellen, P Heusch… - Diagnostic and …, 2014 - ncbi.nlm.nih.gov
Fully integrated positron emission tomography (PET)/magnetic resonance imaging (MRI)
scanners have been available for a few years. Since then, the number of scanner …

Prognostic and predictive factors in advanced head and neck squamous cell carcinoma

T Magnes, S Wagner, D Kiem, L Weiss… - International journal of …, 2021 - mdpi.com
Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous disease arising
from the mucosa of the upper aerodigestive tract. Despite multimodality treatments …

[HTML][HTML] Dynamics of cell-free tumour DNA correlate with treatment response of head and neck cancer patients receiving radiochemotherapy

FJ Hilke, F Muyas, J Admard, B Kootz, D Nann… - Radiotherapy and …, 2020 - Elsevier
Purpose Definitive radiochemotherapy (RCTX) with curative intent is one of the standard
treatment options in patients with locally advanced head and neck squamous cell carcinoma …

Relationship between tumor mutational burden, PD-L1, patient characteristics, and response to immune checkpoint inhibitors in head and neck squamous cell …

KM Burcher, JW Lantz, E Gavrila, A Abreu, JT Burcher… - Cancers, 2021 - mdpi.com
Simple Summary Immunotherapy has prompted a dramatic change in the management of
head and neck squamous cell carcinoma (HNSCC), but the percentage of patients …